Drug Companies Spend Nearly $100 Million to
The number of drug company lobbyists increased from 2001 to 2002, along with
the amount spent on lobbying activities. In all, the drug industry spent close
to $100 million--a record amount.
Drug companies are most interested in influencing issues related to
prescription-drug benefits for Medicare recipients, generic drugs, and imported
prescription drugs from Canada.
Published on 6/24/2003
in the Wall Street Journal Drug Industry Sees
Increase in Lobbying by Staff Writer
WASHINGTON -- The drug industry hired 675 lobbyists from 138 firms and spent
a record $91.4 million on lobbying activities last year, according to twin
studies released by Public Citizen's Congress Watch.
The number of lobbyists increased 4% from 2001 while spending rose 12%,
according to Public Citizen, a nonprofit consumer-advocacy group founded by
Ralph Nader. Public Citizen counted 26 former members of Congress among the
drug-industry lobbyists, and 342 lobbyists with ties to the federal government.
Jeff Trewhitt, a spokesman for the Pharmaceutical Research and Manufacturers
of America, the main trade group for the drug industry, said the group hadn't
seen the report and had no immediate comment.
Since 1997, the industry has spent a total of $650 million lobbying Congress,
with $478 million spent on direct efforts and $172 million on federal campaigns,
TV ads, hiring academics, funding nonprofits and other activities, Public
The drug industry's biggest issues are shaping the inclusion of a
prescription-drug benefit for Medicare recipients, keeping generic brands from
hitting the market earlier, and barring drug imports from Canada.